type |
Ex - Dividend Date |
payment date |
value |
|---|---|---|---|
| Dividends | 12/30/2025 | 01/08/2026 | 0.14300000 |
| Dividends | 12/31/2021 | 01/07/2022 | 0.003940 |
| Dividends | 12/14/2021 | 12/21/2021 | 0.11415000 |
| Dividends | 12/15/2020 | 12/23/2020 | 0.05178000 |
| Company name | Ticker | Asset type | Sector | Market cap | % in ETF |
|---|---|---|---|---|---|
| GH | Stock | Healthcare | US$ 21.66 B | 9,29% | |
| NTRA | Stock | Healthcare | US$ 47.23 B | 8,40% | |
| KRYS | Stock | Healthcare | US$ 11.00 B | 5,91% | |
| ADPT | Stock | Healthcare | US$ 3.92 B | 4,31% | |
| LGND | Stock | Healthcare | US$ 5.78 B | 4,30% | |
| TWST | Stock | Healthcare | US$ 8.21 B | 3,73% | |
| BBIO | Stock | Healthcare | US$ 14.63 B | 3,38% | |
| TVTX | Stock | Healthcare | US$ 6.27 B | 3,20% | |
| VRTX | Stock | Healthcare | US$ 141.42 B | 2,89% | |
| CTVA | Stock | Basic Materials | US$ 58.62 B | 2,77% | |
| MEDP | Stock | Healthcare | US$ 16.56 B | 2,63% | |
| UTHR | Stock | Healthcare | US$ 20.91 B | 2,37% | |
| LLY | Stock | Healthcare | US$ 1.02 T | 2,34% | |
| REGN | Stock | Healthcare | US$ 86.84 B | 2,31% | |
| AZN | Stock | Healthcare | US$ 189.83 B | 2,18% | |
| RGEN | Stock | Healthcare | US$ 9.46 B | 1,94% | |
| ARGX | Stock | Healthcare | US$ 65.51 B | 1,73% | |
| TEM | Stock | Healthcare | US$ 11.66 B | 1,71% | |
| NBIX | Stock | Healthcare | US$ 15.82 B | 1,62% | |
Charles River Laboratories
|
CRL | Stock | Healthcare | US$ 14.13 B | 1,53% |
| JAZZ | Stock | Healthcare | US$ 16.02 B | 1,46% | |
| CDNA | Stock | Healthcare | US$ 2.58 B | 1,33% | |
| PRAX | Stock | Healthcare | US$ 9.82 B | 1,29% | |
| BNTX | Stock | Healthcare | US$ 26.06 B | 1,28% | |
| PTCT | Stock | Healthcare | US$ 5.78 B | 1,21% | |
| GRAL | Stock | Healthcare | US$ 3.59 B | 1,21% | |
| STOK | Stock | Healthcare | US$ 1.92 B | 1,16% | |
| INSM | Stock | Healthcare | US$ 27.58 B | 1,08% | |
| IQV | Stock | Healthcare | US$ 43.80 B | 1,07% | |
| RPRX | Stock | Healthcare | US$ 36.91 B | 1,05% | |
| VCYT | Stock | Healthcare | US$ 3.42 B | 1,03% | |
| RVMD | Stock | Healthcare | US$ 45.01 B | 1,01% | |
| KNSA | Stock | Healthcare | US$ 5.99 B | 1,01% | |
Samsung Biologics Co Ltd
|
207940 | Stock | Healthcare | US$ 66.98 T | 0,98% |
| TXG | Stock | Healthcare | US$ 8.16 B | 0,97% | |
| CRSP | Stock | Healthcare | US$ 5.46 B | 0,96% | |
| HNGE | Stock | Healthcare | US$ 7.32 B | 0,87% | |
Sartorius Aktiengesellschaft
|
SRT3 | Stock | Healthcare | US$ 16.76 B | 0,87% |
| TMO | Stock | Healthcare | US$ 228.66 B | 0,86% | |
| ANAB | Stock | Healthcare | US$ 1.70 B | 0,81% | |
| ETON | Stock | Healthcare | US$ 1.67 B | 0,77% | |
| BEAM | Stock | Healthcare | US$ 3.04 B | 0,75% | |
|
First Tracks Biotherapeutics
|
TRAX | Stock | Healthcare | US$ 1.52 B | 0,72% |
| CDNS | Stock | Technology | US$ 80.73 B | 0,66% | |
| AXSM | Stock | Healthcare | US$ 10.91 B | 0,66% | |
| A | Stock | Healthcare | US$ 42.54 B | 0,62% | |
| DHR | Stock | Healthcare | US$ 153.85 B | 0,61% | |
| GMAB | Stock | Healthcare | US$ 133.07 B | 0,55% | |
| TGTX | Stock | Healthcare | US$ 8.57 B | 0,52% | |
| QGEN | Stock | Healthcare | US$ 8.98 B | 0,51% | |
| MRNA | Stock | Healthcare | US$ 58.11 B | 0,50% | |
Mineralys Therapeutics, Inc. Common Stock
|
MLYS | Stock | Healthcare | US$ 2.49 B | 0,50% |
| CELC | Stock | Healthcare | US$ 4.50 B | 0,47% | |
Roivant Sciences Ltd
|
ROIV | Stock | Healthcare | US$ 26.61 B | 0,46% |
Cogent Biosciences Inc
|
UMRX | Stock | Healthcare | US$ 73.23 M | 0,42% |
Average Investor10 user rating
4.0
(0 people)
Franklin Templeton ETF Trust - Franklin Genomic Advancements ETF (United States) is an exchange-traded fund (ETF), with assets under management totaling $32.38 million.
Over the past 12 months, Franklin Templeton ETF Trust - Franklin Genomic Advancements ETF recorded a return of 40.24%, with its price trading between $29.85 and $43.51 during the same period.
The ETF is traded under the ticker HELX.
The current price of HELX is $43.15. You can track the real-time price chart, review historical performance, and access detailed information about this ETF on the platform.
HELX is currently trading at $43.15, with a market capitalization of approximately $32.384.066,00. Over the past year, the ETF has delivered a 40.24% return, based on share price performance.
Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.
You can invest in HELX through a brokerage account that provides access to the exchange where it is listed. After opening and funding your account, search for the ticker symbol HELX, select the number of shares you wish to purchase, and place your order.
In certain markets, similar exposure may also be available through locally listed products that track the same index.
Over the past month, HELX has returned 0.09%, and 40.24% over the past year.
If you were to purchase 100 shares of HELX at the current price of $43.15, your total investment would be $4,315.00.
After 1 month the profitability would be $4,318.88.
Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.
Sign in with your social account or email
Create your account
Already have an account? Login
Tesla
Dividend Schedule
Ranking of Stocks
Ranking of Brazilian ETFs
Crypto Rankings
